Astrana Health (NASDAQ:ASTH) Reaches New 12-Month Low - Here's What Happened

Shares of Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) reached a new 52-week low on Friday . The company traded as low as $22.25 and last traded at $22.37, with a volume of 161931 shares trading hands. The stock had previously closed at $23.86.Get Astrana Health alerts:Astrana Health Trading Down 6.5%The company has a market cap of $1.25 billion, a P/E ratio of 30.89, a price-to-earnings-growth ratio of 0.88 and a beta of 0.84. The stock has a 50-day moving average of $24.65 and a two-hundred day moving average of $29.66. The company has a debt-to-equity ratio of 0.54, a quick ratio of 1.70 and a current ratio of 1.70. Astrana Health (NASDAQ:ASTH - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.09). Astrana Health had a net margin of 1.56% and a return on equity of 4.90%. The company had revenue of $620.39 million for the quarter, compared to analysts' expectations of $628.11 million. During the same quarter last year, the firm posted $0.31 earnings per share. Astrana Health's revenue for the quarter was up 53.4% on a year-over-year basis. On average, equities research analysts predict that Astrana Health, Inc. will post 1.15 earnings per share for the current year. Institutional Inflows and OutflowsHedge funds have recently modified their holdings of the business. Pilgrim Partners Asia Pte Ltd purchased a new stake in Astrana Health during the fourth quarter worth $40,000. Quarry LP grew its position in Astrana Health by 35.5% during the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock worth $57,000 after purchasing an additional 471 shares during the period. Covestor Ltd grew its position in Astrana Health by 777.6% during the 1st quarter. Covestor Ltd now owns 2,001 shares of the company's stock worth $62,000 after purchasing an additional 1,773 shares during the period. AlphaQuest LLC boosted its stake in shares of Astrana Health by 144.2% during the 1st quarter. AlphaQuest LLC now owns 4,883 shares of the company's stock worth $151,000 after acquiring an additional 2,883 shares in the last quarter. Finally, US Bancorp DE boosted its stake in shares of Astrana Health by 21.3% during the 1st quarter. US Bancorp DE now owns 5,791 shares of the company's stock worth $180,000 after acquiring an additional 1,015 shares in the last quarter. Institutional investors own 52.77% of the company's stock. Astrana Health Company Profile (Get Free Report)Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.Recommended StoriesFive stocks we like better than Astrana HealthWhat is the Dogs of the Dow Strategy? Overview and ExamplesRocket Lab Reports Next Week: Here’s What Investors Should KnowThe Most Important Warren Buffett Stock for Investors: His OwnApple Stock: Big Earnings, Small Move—Time to Buy?Best Stocks Under $10.00 Amazon's Earnings: What Comes Next and How to Play ItThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Astrana Health Right Now?Before you consider Astrana Health, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astrana Health wasn't on the list.While Astrana Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here